ÀáÀÚ´Â ³ª¶ó ½Ã¸®Áî 3. ÄÚºñµå-19 È£ÈíºÎÀü Ä¡·á¹ý: õġ¿Í ¼öÀç°¡ Äڷγª ¹ÙÀÌ·¯½º¸¦ ¸¸³µÀ» ¶§INFOMEDPRESS, 2021. 8. 26. - 192ÆäÀÌÁö Çѱ¹ »çȸ´Â ÇöÀç ¼¼µµÁ¤Ä¡ ½ÃÀý·Î µÇµ¹¾Æ°¡°í ÀÖ´Ù. ÆíÇÑ ±æ, ½¬¿î ±æ, ÇöÀ縦 ÁöŰ´Â ±æ, ´õ ÀÌ»ó Æ¯ÀÌÇÑ ¾Æ¹« °Íµµ ÇÏÁö ¾Ê´Â ±æ, °ÇÑ ÀÚ¿¡°Ô ÀÇÁöÇÏ¿© ±ÇÀ§¸¦ ÀÎÁ¤¹Þ´Â ±æ À§¿¡ ¿ì¸® ±¹¹ÎµéÀ» ¿Ã·Á ¼¼¿î ÀÚµéÀÌ µæ¼¼ÇÑ´Ù. µ¶¸³¿îµ¿°¡µé°ú ÇÔ²² ¿ì¸®ÀÇ ±Ù°£À» Çü¼ºÇÑ ±Ù¸éÇϰí Èñ»ýÀûÀÌ°í º¸¼öÀûÀÎ ºÎ¸ð ¼¼´ë ³ëÀε鿡°Ô ¿ì¸®´Â ÇÏ¸é ¾ÈµÇ´Â ÇൿÀ» Çß´Ù. ÆÒµ¥¹Í½Ã´ë°¡ µÇ¾ú´Âµ¥ ³ëÀεéÀÇ »ç¸ÁÀÌ ¾ÐµµÀûÀ¸·Î ´Ã¾ú´Âµ¥ ³ëÀεéÀ» º¸È£ÇÏÁö ¾Ê¾Ò´Ù. Ä¡¸Å ȯÀڵ鿡°Ô ½Å¼¼´ë ¼öÀçµéÀº Ä¡¸Å¾à°ú Á¤½Å¾à¹°À» ¸Ô¿´°í ½Åü¸¦ °á¹ÚÇß°í ºÎ¸ð Àç»êÀ» »©¾Ñ¾ú°í ÀÏÂï Á×µµ·Ï ÇÕ¹ýÈÇß´Ù. ÀüÅë °¡Ä¡¿Í È¿µµ¸¦ Áß½ÃÇÏ´Â º¸¼öÀÇ °¡Ä¡¸¦ ¸»»ìÇϱâ À§ÇÏ¿© º¸¼ö¡¤º¸¼ö¡¤º¸¼öÇÏ¸é¼ ´õ·¯¿î ¿ë¾îÀÎ °Íó·³ ¶°¹úÀÌ´Â ¹æ¼ÛÁøÇàÀÚ¸¦ ºñÆÇÇÏÁö ¾Ê¾Ò´Ù. ÀÌ Ã¥ÀÇ ÀúÀÚ´Â »ó±â ¼öÀçµéÀÇ »î°ú´Â ¾Æ¿¹ Á¤¹Ý´ë·Î »ì±â·Î °á½ÉÇß´Ù. ±×¸®°í ½Çõ¿¡ ¿Å°å´Ù. ¹«¾ùº¸´Ùµµ ¼ÒÁßÇÑ ½Ã¹ÎÀÇ »ý¸íÀ» ±¸Çϱâ À§ÇÏ¿© ÀÌ Ã¥À» ½Ã¹Î¿¡°Ô Á¦ÃâÇÑ´Ù. |
¸ñÂ÷
8 | |
9 | |
13 | |
15 | |
21 | |
´ä¼ÕÀÌ ÄÚºñµå19¸¦ Ä¡·áÇÒ ¼ö ÀÖ´Â ³× °¡Áö ¹æ¾î ±âÀü¿¡ ´ëÇÑ °¡¼³ ¼³¸í | 24 |
COVID19 ÀÓ»ó 3»ó¿¡ »ç¿ëµÈ ¿À·¡µÈ ¾à ´ä¼Õ | 44 |
SARSCoV2 ±Þ¼ºÈ£ÈíºÎÀüÀÇ Ä¡·áÁ¦´Â Á¸ÀçÇÑ´Ù | 47 |
2 Materials and Methods | 84 |
3 Results | 85 |
4 Discussion | 93 |
5 Conclusions | 99 |
References | 101 |
Specific Treatment Exists for SARSCoV2 ARDS | 108 |
Supplementary material for | 125 |
The Method and Results of a Treatment Targeting SARSCoV2Activated Inflammasomes | 136 |
È£ÈíºÎÀü Ä¡·á¹ýÀ» Áõ¸íÇÑ ÀÓ»ó ¿¬±¸ °úÁ¤ | 50 |
½ÃȲÁ¦¿Í ºÎÀÚµéÀ» À§ÇÑ ´õ ¿À·¡ »ç´Â ¾àÀº ¾ÖÃÊ¿¡ ¾ø¾ú´Ù | 53 |
ÀÚ¿¬ °úÇп¡¼ õÀç°¡ ¾ø´Â ÀÌÀ¯ | 56 |
Áúº´°ü¸®Ã» »ýȰġ·á¼¾ÅÍ ÄÚºñµå19 ȯÀÚ Ä¡·á Áöħ | 59 |
64 | |
Reference | 69 |
Commentary for the Elderly in the pandemic era | 77 |
Reference | 79 |
44Diaminodiphenyl Sulfone DDS as an Inflammasome Competitor | 81 |
Introduction | 137 |
Methods | 138 |
Results | 142 |
Discussion | 145 |
Conclusion | 146 |
References | 147 |
Preparation for Randomized Controlled Trial of dapsone for Covid19 ARDS | 149 |
References | 182 |
ÀÚÁÖ ³ª¿À´Â ´Ü¾î ¹× ±¸¹®
ACE2 acute Alzheimer¡¯s disease amyloid ARDS ARDS onset BiPAP brain cells chi-square Choi chronic cimetidine Clin clinical coronavirus COVID-19 ARDS COVID-19 patients COVID19 cytokines dapsone dapsone hypersensitivity syndrome Dementia Dermatol drug familial Mediterranean fever FIO2 FIO2 requirement Hansen¡¯s HD patients HFNC Hunt Regional Hospital hypoxia infectious diseases inflammasome competitor inflammation inflammatory influenza Journal Korea Lee J-h leprosy leprosy patients mechanical ventilation methemoglobinemia molecular molecular docking myeloperoxidase NF-kB nucleophilic oxidation p-value pandemic Park pneumonia protein reactions receptor result is significant SARS-CoV SARS-CoV-2 infection side effects Sorok Sorok Island Sorokdo National Hospital Statistics sulfone T-Test Calculator therapy ubiquitination unspecified vaccine viral virus Zhang °°´Ù °³ÀÇ °ÍÀ¸·Î °ÍÀ» °ÍÀÌ °ÍÀÌ´Ù ±×·±µ¥ ´Ü¹éÁú ´ä¼Õ ´ä¼ÕÀº ´ä¼ÕÀ» ´ä¼ÕÀÌ ´ëÇÑ µÇ¾ú´Ù ¸Å¿ì ¹Ù´Ù ¼¼Æ÷ ¾Æ¹Ð·ÎÀÌµå ¾à¹° ¿¬±¸ ¿¬±¸¸¦ À̾ú´Ù ÀÓ»ó ÀÖ´Ù´Â ÀÖ¾ú´Ù Ä¡·á Ä¡·á¹ýÀ» ÇÑ´Ù Çߴ٠ȣÈí±â È¿°ú°¡